News
WGTS suggests potential treatment options for 79% of patients and identifies a probable tissue of origin in 77% of cases, outperforming panel testing. WGTS is feasible on archived tissue with a 97 ...
Gary Berkowitz asked some of America’s top voiceover artists how they like to be coached and what helps them deliver their ...
Hosted on MSN16d
Genomic testing aids precision therapy and tissue of origin identification for cancers whose primary site is unknownWhereas previous studies have suggested that genomic testing only works well if done on fresh tumor samples, this study also demonstrated the feasibility of using WGTS on archived tissue samples ...
Whole genome and transcriptome sequencing (WGTS) is proving significantly more effective than conventional gene panel testing in diagnosing and treating cancer of unknown primary (CUP), according to ...
The funds are not sponsored, endorsed, sold or promoted by SPDR® Gold Trust and WGTS (together with their affiliates hereinafter referred to as the "Corporations"). The Corporations have not passed on ...
A phase II study of pevonedistat in combination with carboplatin and paclitaxel in advanced intrahepatic cholangiocarcinoma: ECOG-ACRIN EA2187. Real-world validation of the risk estimation of tumor ...
Analyzing the relationship between glutaminase expression and features of the immune tumor microenvironment in epithelial ovarian cancer using imaging mass cytometry. This is an ASCO Meeting Abstract ...
Cancer of unknown primary is difficult to treat due to high heterogeneity in treatment response depending on the original site. Here, the authors use DNA methylation data to develop a machine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results